Health Cor Management, L.P. Incyte Corp Call Options Transaction History

Health Cor Management, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	BUY	$79.87 - $87.53 $21.3 Million - $23.4 Million	267,000 New	267,000 $22.5 Million
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $36.5 Million - $50.4 Million	-600,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $49.8 Million - $60.6 Million	600,000 New	600,000 $50 Million

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.